Loading clinical trials...
Loading clinical trials...
A Safety, Tolerability and Efficacy Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects Birth to 48 Months Old With Reactive Airways Disease in an Acute Setting
Conditions
Interventions
Levalbuterol HCl Inhalation Solution
Levalbuterol HCl Inhalation Solution
+1 more
Locations
34
United States
Little Rock, Arkansas, United States
Corona, California, United States
Englewood, California, United States
Huntington Beach, California, United States
Long Beach, California, United States
Sacramento, California, United States
Start Date
February 1, 2001
Primary Completion Date
July 1, 2002
Completion Date
July 1, 2002
Last Updated
February 22, 2012
Lead Sponsor
Sumitomo Pharma America, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions